Daily Archives: September 17, 2020
WHO Guidance: Allocation and prioritization of COVID-19 vaccination
17 Sep, 2020 | 09:42h | UTCCommentary: World Health Organization announces distribution plan for COVID-19 vaccine – ABD News
Related: An ethical framework for global vaccine allocation – Science
A case of probable Parkinson’s disease after SARS-CoV-2 infection
17 Sep, 2020 | 09:40h | UTCA case of probable Parkinson’s disease after SARS-CoV-2 infection – The Lancet Neurology
Commentary on Twitter
Parkinson's disease diagnosed after #SARSCoV2 in a 45 year-old-man https://t.co/SPLKDm1A2U @TheLancetNeuro
This has been reported with many other viruses but appears to be the 1st case with covid, very extensive workup pic.twitter.com/AtQfQXxjtm— Eric Topol (@EricTopol) September 17, 2020
How COVID-19 can damage the brain
17 Sep, 2020 | 09:36h | UTCHow COVID-19 can damage the brain – Nature
Commentary on Twitter
How COVID-19 can damage the brain https://t.co/uQUS5y9AXU 125 people in the United Kingdom with COVID-19 who had neurological or psychiatric effects. 62% had strokes and haemorrhages, and 31% had altered mental states, such as confusion or prolonged unconsciousness.
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
Detection of SARS-CoV-2 with a CRISPR-based test
17 Sep, 2020 | 09:38h | UTCDetection of SARS-CoV-2 with a CRISPR-Based Test – New England Journal of Medicine
Fast coronavirus tests: what they can and can’t do
17 Sep, 2020 | 09:35h | UTCFast coronavirus tests: what they can and can’t do – Nature
Opinion: “Is lockdown worth the pain? No, it’s a sledgehammer and we have better options”
17 Sep, 2020 | 09:31h | UTCIs lockdown worth the pain? No, it’s a sledgehammer and we have better options – The Conversation
[Press release – not published yet] Eli Lilly reports first, promising results for an antibody against COVID-19
17 Sep, 2020 | 09:28h | UTCEli Lilly reports first, promising results for an antibody against COVID-19 – Science
Press release: Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting
Updated Cochrane Rapid Review assesses the effectiveness of quarantine during the COVID-19 pandemic
17 Sep, 2020 | 09:32h | UTC
Commentary on Twitter
Recently published: https://t.co/lLM4ehhyro Updated @cochranecollab Rapid Review assesses the effectiveness of #quarantine during the #COVID-19 pandemic. It includes 51 relevant studies – 22 more than in the first version. @CochraneAus pic.twitter.com/ME5CiuTzUa
— The Cochrane Library (@CochraneLibrary) September 16, 2020
CDC Study: Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19
17 Sep, 2020 | 09:29h | UTC
Commentary on Twitter
.@CDCMMWR report looking at almost 600 hospitalized pregnant women with #COVID19 found that pregnant women can have severe illness and poor birth outcomes, such as the mother requiring intensive care, pregnancy loss, and preterm birth. Learn more: https://t.co/g7WsFWJdDs. pic.twitter.com/Ve0dnGNTDM
— CDC (@CDCgov) September 16, 2020
When to replicate systematic reviews of interventions: Consensus checklist
17 Sep, 2020 | 09:23h | UTCWhen to replicate systematic reviews of interventions: consensus checklist – The BMJ
Commentary on Twitter
Delighted this is out today! Thanks to @CIHR_IRSC funding and great team: When to replicate systematic reviews of interventions: consensus checklist https://t.co/1WDc9a6VBq
— Vivian A Welch (@vawelch) September 15, 2020
Investigating whether blood type is linked to COVID-19 risk
17 Sep, 2020 | 09:26h | UTCInvestigating Whether Blood Type Is Linked to COVID-19 Risk – JAMA
Commentary on Twitter
Researchers find no relationship between blood type and severe #COVID19, despite early studies suggesting possible higher risk for those with type A. “The basic science on this is extremely weak.” https://t.co/tYreg896DK
— JAMA (@JAMA_current) September 17, 2020
Estimating risk ratios and risk differences: Alternatives to odds ratios
17 Sep, 2020 | 09:25h | UTCEstimating Risk Ratios and Risk Differences: Alternatives to Odds Ratios – JAMA (free for a limited period)
Commentary on Twitter
Why Risk Ratios and Risk Differences are better than odds ratios https://t.co/zGOKAMQDHI via @JAMA_current part of @JAMANetwork
— Ed Livingston (@ehlJAMA) September 16, 2020
Randomized trial: Opportunistic screening vs. usual care for detection of atrial fibrillation in primary care
17 Sep, 2020 | 09:21h | UTC
Commentary on Twitter
Opportunistic screening for atrial fibrillation in primary care patients, aged 65 and over, did not increase the detection rate of atrial fibrillation, finds this cluster randomised controlled trialhttps://t.co/PnjTZO9IKC
— The BMJ (@bmj_latest) September 16, 2020
[Abstract Only] Two-year, randomized, controlled trial of belimumab in lupus nephritis
17 Sep, 2020 | 09:20h | UTCTwo-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis – New England Journal of Medicine (link to abstract – $ for full-text)
Lifelong aspirin for all in the secondary prevention of chronic coronary syndrome: Still sacrosanct or is reappraisal warranted?
17 Sep, 2020 | 09:19h | UTCLifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or is Reappraisal Warranted? – Circulation (free for a limited period)